{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:17:38Z","timestamp":1791908258253,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009002","name":"Shanghai Institute of Science and Technology","doi-asserted-by":"publisher","award":["2018-2020-FWTX-1102"],"award-info":[{"award-number":["2018-2020-FWTX-1102"]}],"id":[{"id":"10.13039\/501100009002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.phymed.2025.156556","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T01:49:06Z","timestamp":1740275346000},"page":"156556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy and safety of Shexiang Baoxin Pill in patients with angina and non-obstructive coronary arteries: A multicenter, randomized, double-blind, placebo-controlled, phase \u2163 clinical trial"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8363-1286","authenticated-orcid":false,"given":"Zhiqing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-4823","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9065-3365","authenticated-orcid":false,"given":"Lihong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4300-0209","authenticated-orcid":false,"given":"Mingqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piqiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phymed.2025.156556_bib0001","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ejhf.2010","article-title":"Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction","volume":"23","author":"Ahmad","year":"2021","journal-title":"Eur. J. Heart. Fail."},{"key":"10.1016\/j.phymed.2025.156556_bib0002","first-page":"30","article-title":"INOCA\/ANOCA: mechanisms and novel treatments","author":"Ashokprabhu","year":"2023","journal-title":"Am. Heart. J. Plus."},{"issue":"11","key":"10.1016\/j.phymed.2025.156556_bib0003","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phymed.2025.156556_bib0004","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/cvr\/cvaa006","article-title":"Treatment of coronary microvascular dysfunction","volume":"116","author":"Bairey Merz","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.phymed.2025.156556_bib0005","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.21037\/apm-21-2233","article-title":"A systematic review and meta-analysis of clinical research on treating angina pectoris of coronary heart disease with traditional Chinese medicine to promote blood circulation and remove blood stasis","volume":"10","author":"Chen","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"3","key":"10.1016\/j.phymed.2025.156556_bib0006","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.121.319644","article-title":"IMPROvE-CED trial: intracoronary autologous CD34+ cell therapy for treatment of coronary endothelial dysfunction in patients with angina and Nonobstructive coronary arteries","volume":"130","author":"Corban","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2025.156556_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.731059","article-title":"Pathophysiologic basis and diagnostic approaches for ischemia with non-obstructive coronary arteries: a literature review","volume":"9","author":"Fu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.phymed.2025.156556_bib0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CM9.0000000000001257","article-title":"Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial","volume":"134","author":"Ge","year":"2021","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.phymed.2025.156556_bib0009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjcard.2021.04.029","article-title":"Seattle angina pectoris questionnaire and canadian cardiovascular society angina categories in the assessment of total coronary atherosclerotic burden","volume":"152","author":"Guimar\u00e3es","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phymed.2025.156556_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7644648","article-title":"Shexiang baoxin pill for acute myocardial infarction: clinical evidence and molecular mechanism of antioxidative stress","volume":"2021","author":"Guo","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"issue":"1","key":"10.1016\/j.phymed.2025.156556_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101420","article-title":"Ischemia with no obstructive arteries (INOCA): a review of the prevalence, diagnosis and management","volume":"48","author":"Hansen","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"issue":"3","key":"10.1016\/j.phymed.2025.156556_bib0012","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/FJC.0000000000000967","article-title":"Shexiang baoxin pill attenuates ischemic injury by promoting angiogenesis by activation of aldehyde dehydrogenase 2","volume":"77","author":"Hu","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156556_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13256-023-04316-y","article-title":"Recurrent syncope due to ischemia with non-obstructive coronary artery disease: a case report","volume":"18","author":"Huang","year":"2024","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.phymed.2025.156556_bib0014","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2017.06.012","article-title":"Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization","volume":"263","author":"Huang","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2025.156556_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117925","article-title":"The efficacy of Chinese herbal drugs for adults with angina pectoris: bayesian network meta-analysis of 331 RCTs involving 36,467 individuals","volume":"326","author":"Jia","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"37","key":"10.1016\/j.phymed.2025.156556_bib0016","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur. Heart. J."},{"issue":"2","key":"10.1016\/j.phymed.2025.156556_bib0017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11655-022-3627-3","article-title":"Therapeutic efficacy of shexiang baoxin pill combined with exercise in patients with heart failure with preserved ejection fraction: a single-center, double-blind, randomized controlled trial","volume":"29","author":"Liu","year":"2023","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phymed.2025.156556_bib0018","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3389\/fphar.2018.01161","article-title":"Shexiang Baoxin Pill, Derived From the Traditional Chinese Medicine, Provides Protective Roles Against Cardiovascular Diseases","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156556_bib0019","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cbi.2017.03.012","article-title":"Vasodilatory effect of nitroglycerin in Japanese subjects with different aldehyde dehydrogenase 2 (ALDH2) genotypes","volume":"276","author":"Miura","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2025.156556_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2021.10.037","article-title":"Longitudinal association between angina pectoris and quality of life","volume":"164","author":"Schopfer","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phymed.2025.156556_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115279","article-title":"Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction","volume":"293","author":"Song","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.phymed.2025.156556_bib0022","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjcard.2017.12.025","article-title":"Pharmacologic treatment of patients with myocardial ischemia with no obstructive coronary artery disease","volume":"121","author":"Turgeon","year":"2018","journal-title":"Am. J. Cardiol."},{"issue":"36","key":"10.1016\/j.phymed.2025.156556_bib0023","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.phymed.2025.156556_bib0024","article-title":"Effects of shexiang baoxin pill for coronary microvascular function: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156556_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115186","article-title":"Shexiang Baoxin Pill treats acute myocardial infarction by promoting angiogenesis via GDF15-TRPV4 signaling","volume":"165","author":"Wei","year":"2023","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2025.156556_bib0026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fphar.2018.00137","article-title":"Shexiang baoxin pill corrects metabolic disorders in a rat model of metabolic syndrome by targeting mitochondria","volume":"9","author":"Wei","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156556_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2672516","article-title":"Efficacy and safety of shexiang baoxin pill for coronary heart disease after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"2021","author":"Wei","year":"2021","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.phymed.2025.156556_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1002713","article-title":"Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: a systematic review and meta-analysis of 42 randomized controlled trials","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.phymed.2025.156556_bib0029","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11883-022-01044-4","article-title":"Non-obstructive plaque and treatment of INOCA: more to be learned","volume":"24","author":"Ya'Qoub","year":"2022","journal-title":"Curr. Atheroscler. Rep."},{"issue":"7","key":"10.1016\/j.phymed.2025.156556_bib0030","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1248\/cpb.54.1058","article-title":"Chemical fingerprinting of Shexiang Baoxin Pill and simultaneous determination of its major constituents by HPLC with evaporative light scattering detection and electrospray mass spectrometric detection","volume":"54","author":"Yan","year":"2006","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.phymed.2025.156556_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154336","article-title":"Shexiang Baoxin Pill attenuates myocardial ischemia\/reperfusion injury by activating autophagy via modulating the ceRNA-Map3k8 pathway","volume":"104","author":"Yu","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2025.156556_bib0032","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/CM9.0000000000002527","article-title":"Effectiveness and safety of Shexiang Baoxin Pill (MUSKARDIA) in patients with stable coronary artery disease and concomitant diabetes mellitus: a subgroup analysis of a randomized clinical trial","volume":"136","author":"Zhou","year":"2023","journal-title":"Chin. Med. J. (Engl)"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:18:06Z","timestamp":1778559486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325001965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"alternative-id":["S0944711325001965"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156556","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of Shexiang Baoxin Pill in patients with angina and non-obstructive coronary arteries: A multicenter, randomized, double-blind, placebo-controlled, phase \u2163 clinical trial","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156556"}}